ANKH Chromosome 5
ANKH inorganic pyrophosphate transport regulator
Upload your DNA to see your personal genotypes for variants in ANKH.
What This Gene Does
This gene encodes a multipass transmembrane protein that is expressed in joints and other tissues and controls pyrophosphate levels in cultured cells. Progressive ankylosis-mediated control of pyrophosphate levels has been suggested as a possible mechanism regulating tissue calcification and susceptibility to arthritis in higher animals. Mutations in this gene have been associated with autosomal dominant craniometaphyseal dysplasia. [provided by RefSeq, Jul 2008]
Gene Info
Gene Group
"MicroRNA protein coding host genes|Solute carrier family 62"
Locus Type
gene with protein product
Location
5p15.2
Ensembl
ENSG00000154122
Associated Conditions (7)
Chondrocalcinosis 2
ANKH-related disorder
Craniometaphyseal dysplasia
autosomal dominant
Inborn genetic diseases
CHONDROCALCINOSIS 2
SPORADIC
Key Variants
RS121908410
Conflicting classifications of pathogenicity
Chondrocalcinosis 2, ANKH-related disorder, Chondrocalcinosis 2
Health Risk
RS139013878
Conflicting classifications of pathogenicity
Health Risk
RS140150501
Conflicting classifications of pathogenicity
Craniometaphyseal dysplasia, autosomal dominant, Chondrocalcinosis 2
Health Risk
RS1407969814
Conflicting classifications of pathogenicity
Health Risk
RS148228793
Conflicting classifications of pathogenicity
ANKH-related disorder, ANKH-related disorder
Health Risk
RS148526515
Conflicting classifications of pathogenicity
Inborn genetic diseases, Inborn genetic diseases
Health Risk
RS187972211
Conflicting classifications of pathogenicity
Chondrocalcinosis 2, Craniometaphyseal dysplasia, autosomal dominant
Health Risk
RS199583793
Conflicting classifications of pathogenicity
Health Risk
RS199664007
Conflicting classifications of pathogenicity
Chondrocalcinosis 2, Craniometaphyseal dysplasia, autosomal dominant
Health Risk
RS199961741
Conflicting classifications of pathogenicity
Craniometaphyseal dysplasia, autosomal dominant, Chondrocalcinosis 2
Health Risk
RS200216941
Conflicting classifications of pathogenicity
Chondrocalcinosis 2, Craniometaphyseal dysplasia, autosomal dominant
Health Risk
RS544848340
Conflicting classifications of pathogenicity
Chondrocalcinosis 2, Craniometaphyseal dysplasia, autosomal dominant
Health Risk
All Variants (30)
| RSID | Category | Clinical Significance | Conditions |
|---|---|---|---|
| RS121908410 | Health Risk | Conflicting classifications of pathogenicity | Chondrocalcinosis 2, ANKH-related disorder, Chondrocalcinosis 2 |
| RS139013878 | Health Risk | Conflicting classifications of pathogenicity | — |
| RS140150501 | Health Risk | Conflicting classifications of pathogenicity | Craniometaphyseal dysplasia, autosomal dominant, Chondrocalcinosis 2 |
| RS1407969814 | Health Risk | Conflicting classifications of pathogenicity | — |
| RS148228793 | Health Risk | Conflicting classifications of pathogenicity | ANKH-related disorder, ANKH-related disorder |
| RS148526515 | Health Risk | Conflicting classifications of pathogenicity | Inborn genetic diseases, Inborn genetic diseases |
| RS187972211 | Health Risk | Conflicting classifications of pathogenicity | Chondrocalcinosis 2, Craniometaphyseal dysplasia, autosomal dominant |
| RS199583793 | Health Risk | Conflicting classifications of pathogenicity | — |
| RS199664007 | Health Risk | Conflicting classifications of pathogenicity | Chondrocalcinosis 2, Craniometaphyseal dysplasia, autosomal dominant |
| RS199961741 | Health Risk | Conflicting classifications of pathogenicity | Craniometaphyseal dysplasia, autosomal dominant, Chondrocalcinosis 2 |
| RS200216941 | Health Risk | Conflicting classifications of pathogenicity | Chondrocalcinosis 2, Craniometaphyseal dysplasia, autosomal dominant |
| RS544848340 | Health Risk | Conflicting classifications of pathogenicity | Chondrocalcinosis 2, Craniometaphyseal dysplasia, autosomal dominant |
| RS550672520 | Health Risk | Conflicting classifications of pathogenicity | Craniometaphyseal dysplasia, autosomal dominant, Chondrocalcinosis 2 |
| RS576051028 | Health Risk | Conflicting classifications of pathogenicity | Chondrocalcinosis 2, Craniometaphyseal dysplasia, autosomal dominant |
| RS745669233 | Health Risk | Conflicting classifications of pathogenicity | Craniometaphyseal dysplasia, autosomal dominant, Chondrocalcinosis 2 |
| RS761349696 | Health Risk | Conflicting classifications of pathogenicity | Chondrocalcinosis 2, Craniometaphyseal dysplasia, autosomal dominant |
| RS761698657 | Health Risk | Conflicting classifications of pathogenicity | Chondrocalcinosis 2, Craniometaphyseal dysplasia, autosomal dominant |
| RS777229764 | Health Risk | Conflicting classifications of pathogenicity | — |
| RS886060088 | Health Risk | Conflicting classifications of pathogenicity | Chondrocalcinosis 2, Craniometaphyseal dysplasia, autosomal dominant |
| RS121908409 | Health Risk | Likely pathogenic | Chondrocalcinosis 2, Chondrocalcinosis 2 |
| RS2477420066 | Health Risk | Likely pathogenic | Craniometaphyseal dysplasia, autosomal dominant, Craniometaphyseal dysplasia |
| RS28939080 | Health Risk | Likely pathogenic | Craniometaphyseal dysplasia, autosomal dominant, Chondrocalcinosis 2 |
| RS121908405 | Health Risk | Pathogenic | Craniometaphyseal dysplasia, autosomal dominant, Chondrocalcinosis 2 |
| RS121908407 | Health Risk | Pathogenic | Chondrocalcinosis 2, Chondrocalcinosis 2 |
| RS121908408 | Health Risk | Pathogenic | CHONDROCALCINOSIS 2, SPORADIC, CHONDROCALCINOSIS 2 |
| RS267606656 | Health Risk | Pathogenic | Craniometaphyseal dysplasia, autosomal dominant, Craniometaphyseal dysplasia |
| RS267606657 | Health Risk | Pathogenic | Craniometaphyseal dysplasia, autosomal dominant, Craniometaphyseal dysplasia |
| RS267606658 | Health Risk | Pathogenic | Craniometaphyseal dysplasia, autosomal dominant, Craniometaphyseal dysplasia |
| RS121908406 | Health Risk | Pathogenic/Likely pathogenic | Craniometaphyseal dysplasia, autosomal dominant, Craniometaphyseal dysplasia |
| RS1579998709 | Health Risk | Pathogenic/Likely pathogenic | Craniometaphyseal dysplasia, autosomal dominant, Craniometaphyseal dysplasia |